Akèy › Kansè pwostat rezistan a kastasyon › Nebraska
Etid klinik pou Kansè pwostat rezistan a kastasyon nan Nebraska
3 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan Nebraska.
Tèks ofisyèl etid la (Anglè)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- NHO Revive Research Institute, LLC, Lincoln
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- XCancer Omaha / Urology Cancer Center, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT0716444364Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
- XCancer, Omaha
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou May 6, 2026 · NCT04868604Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.